BESSY MARTIROSYAN: Open Payments
NPI 1790849883 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 17 payments from 7 companies in 2025. Trend: 2023 $18 · 2024 $255 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $133 |
| E.R. Squibb & Sons, L.L.C. | 3 | $82 |
| Supernus Pharmaceuticals, Inc. | 3 | $67 |
| Alkermes, Inc. | 2 | $50 |
| Abbott Laboratories | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: COBENFY, Qelbree, ABILIFY ASIMTUFII, ARISTADA, ABILIFY MAINTENA, REXULTI, MITRACLIP, Auvelity.
Industry payments across CA — which companies pay providers there.
